兔多克隆抗体to BRDG 1 - Aminoterminal end
Synthetic peptide from the N terminal region of human BRDG 1, conjugated to KLH.
Human prostate carcinoma tissue.
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term.
Preservative: 0.09% Sodium Azide
Concentration information loading...
Protein A purified
ab63056 was purified through a protein A column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
In BCR signaling, appears to function as a docking protein acting downstream of TEC and participates in a positive feedback loop by increasing the activity of TEC.
Contains 1 PH domain.
Contains 1 SH2 domain.
Phosphorylated on tyrosine by TEC.
Information by UniProt
BCR downstream signaling protein 1 antibody
BCR downstream-signaling protein 1 antibody
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BRDG 1 antibody - Aminoterminal end (ab63056)
ab63056, at 1/50 dilution, staining BRDG 1 in formalin-fixed, paraffin-embedded human prostate carcinoma tissue by immunohistochemistry. ab63056 was peroxidase-conjugated to the secondary antibody, followed by DAB staining.
has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"